Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19

被引:4
|
作者
Shakrawal, Jyoti [1 ]
Sharma, Vidhu [2 ]
Goyal, Amit [2 ]
Kumar, Deepak [3 ]
Meena, Seema [1 ]
Tiwari, Sarbesh [4 ]
Jain, Vidhi [5 ]
Elhence, Poonam [6 ]
Soni, Kapil [2 ]
Choudhury, Bikram [2 ]
Bhatnagar, Kavita [1 ]
Garg, Mahendra Kumar [3 ]
Misra, Sanjeev [7 ]
机构
[1] All India Inst Med Sci AIIMS, Dept Ophthalmol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[2] All India Inst Med Sci AIIMS, Dept Otorhinolaryngol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[3] All India Inst Med Sci AIIMS, Dept Gen Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[4] All India Inst Med Sci AIIMS, Dept Diagnost & Intervent Radiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[5] All India Inst Med Sci AIIMS, Dept Microbiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[6] All India Inst Med Sci AIIMS, Dept Pathol & Lab Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[7] All India Inst Med Sci AIIMS, Dept Surg Oncol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
关键词
COVID-19; Transcutaneous retrobulbar Amphotericin B; Rhino-orbital-cerebral-mucormycosis; MANAGEMENT;
D O I
10.1007/s10792-022-02591-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To assess the outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) for rhino-orbital-cerebral-mucormycosis (ROCM) post-COVID-19, as an adjuvant to standard systemic antifungal therapy. Methods In this prospective cohort study involving ROCM patients with clinical/radiological orbital involvement, 44 eyes with ROCM stage >= 3B received TRAMB for 7 consecutive days with liposomal Amphotericin-B (3.5 mg/ml) with a minimum clinical and radiological follow-up of 3 months. All patients received standard systemic antifungal therapy also as per institutional protocol. Data pertaining to demography, systemic status, clinical involvement, imaging, surgical/medical management were also recorded. Potential eyes for exenteration were excluded. Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 12 Given name: [Mahendra Kumar ] Last name [Garg]. Also, kindly confirm the details in the metadata are correct.All author names are presented accurately. Details in the metadata are correct. Thank you. Results Forty-four eyes of 42 patients were included, out of which 30 had diabetes mellitus & 22 had received steroid/oxygen treatment during COVID-19 infection. Forty eyes showed improvement or stable disease on follow-up on radiology. Four eyes which showed progression of the disease in orbit were reaugmented with TRAMB. No patient required exenteration. Subconjunctival haemorrhage occurred in six eyes and temporary blurring of vision in four eyes after TRAMB which resolved spontaneously. Conclusion TRAMB, as an adjuvant to standard systemic antifungal therapy, is associated with a significant reduction or stabilisation of orbital involvement. TRAMB should be considered as an adjuvant therapy for ROCM to reduce disease progression as well as to preserve globe or sight. It has a promising role in preventing potential orbital exenterations.
引用
收藏
页码:1919 / 1926
页数:8
相关论文
共 50 条
  • [21] First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria
    Niyazi, Denis
    Toncheva, Borislava
    Tonchev, Tsvetan
    Dzhenkov, Deyan
    Kalchev, Kalin
    Stoeva, Temenuga
    FUTURE MICROBIOLOGY, 2022, : 1107 - 1113
  • [23] Predisposing factors of rhino-orbital-cerebral mucormycosis in patients with COVID 19 infection
    Pradhan, Pradeep
    Shaikh, Zaid
    Mishra, Abhijeet
    Preetam, C.
    Parida, Pradipta Kumar
    Sarkar, Sourav
    Samal, Dillip Kumar
    Nayak, Anindya
    Chadaram, Srinivas
    Das, Krishna Kinkar
    Chakraborty, Swagata
    Sharma, Prity
    Aswathi, K., V
    Vinusree, K.
    Mittal, Yash
    Sundaram, Kalyana
    Swarup, Anurita
    Adhikari, Asutosh
    Chenniappan, Swathi
    Shah, Anwer
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 2) : 3151 - 3157
  • [24] Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review
    Dave, Tarjani Vivek
    Nair, Akshay Gopinathan
    Joseph, Joveeta
    Freitag, Suzanne K.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2022, 41 (06): : 670 - 679
  • [25] Imaging spectrum of rhino-orbital-cerebral mucormycosis secondary to COVID-19 infection: a reporting checklist
    Deshmukh, Yogeshwari Anay
    Vaid, Sanjay
    Chandorkar, Aparna
    Atre, Ashish
    Patil, Sunil
    POLISH JOURNAL OF RADIOLOGY, 2022, 87 : e333 - e347
  • [26] Predisposing factors of rhino-orbital-cerebral mucormycosis in patients with COVID 19 infection
    Pradeep Pradhan
    Zaid Shaikh
    Abhijeet Mishra
    C. Preetam
    Pradipta Kumar Parida
    Sourav Sarkar
    Dillip Kumar Samal
    Anindya Nayak
    Srinivas Chadaram
    Krishna Kinkar Das
    Swagata Chakraborty
    Prity Sharma
    K. V. Aswathi
    K. Vinusree
    Yash Mittal
    Kalyana Sundaram
    Anurita Swarup
    Asutosh Adhikari
    Swathi Chenniappan
    Anwer Shah
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 : 3151 - 3157
  • [27] Radiological Features of Rhino-Orbital-Cerebral Mucormycosis Complicating COVID-19 Illness: a Pictorial Essay
    Chauhan, N. S.
    Kumar, S.
    Takkar, P.
    Sood, A.
    HONG KONG JOURNAL OF RADIOLOGY, 2022, 25 (03): : 226 - 234
  • [28] Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons
    Kaur, Kirandeep
    Gurnani, Bharat
    INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (05) : 417 - 419
  • [29] High blood sugar as a risk factor for post COVID-19 rhino-orbital-cerebral mucormycosis
    Dubey, S.
    Yadalla, S.
    Prabu, N.
    Dubey, A.
    Ramakrishnan, V.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [30] A clinical study of rhino-orbital-cerebral mucormycosis during the COVID-19 pandemic in western Maharashtra
    Manade, Varsha Vivek
    Kotecha, Megha R.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (09) : 3730 - 3734